Business
TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible
TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible.
About this update from Biostax Corp.
[{"type":"text","content":"\n\n\n\nTNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nTNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible\nPR Newswire\nORLANDO, Fla. and DUBLIN, Sept. 23, 2014\n\n\n\nORLANDO, Fla. and DUBLIN, Sept. 23, 2014 /PRNewswire/ --TNI BioTech, Inc. (OTC-BB: TNIB) (\"we\" or the \"Company\"), a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced that the Depository Trust Company (\"DTC\") has approved our common stock for DTC's Deposit and Withdrawal at Custodian (\"DWAC\") service using a Fast Automated Securities Transfer Service (\"FAST\") transfer agent as the distribution point.  The Company's shareholders holding their securities in street name can now transfer their shares electronically after buying or selling on the open market without the extra expense and delay resulting from the redundant process of requesting and transferring physical certificates. \n\nBenefits to our shareholders as a result of becoming DWAC/FAST approved include reducing the time from weeks to hours for stock deposits and withdrawals into brokerage accounts while eliminating the inherent risks associated with the loss and replacement of physical stock certificates. \n\nThe Company's CEO, Noreen Griffin, stated \"We are pleased to share this corporate development with our shareholders. DTC worked with us to make the Company DWAC/FAST eligible therefore obviating the mandatory surrender of our share certificates for street name shareholders to receive the Cytocom Inc. share dividend.\"  We thank DTC for making this possible for our shareholders. \n\nOur shareholders will receive one common share of Cytocom Inc. for every one share of our common stock held by such shareholders as of 5:00 p.m., Eastern Time, on September 30, 2014, which is the \"record date\" for the share distribution. \n\nShareholders who hold our shares in street name do not need to take any action to receive the Cytocom Inc. share dividend....